Prognosis and mortality of polymyositis and dermatomyositis patients.
about
Idiopathic inflammatory myopathiesCardiac involvement in adult and juvenile idiopathic inflammatory myopathiesSurvival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.Idiopathic inflammatory myopathies.Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study.Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China.Morbidity and mortality in adult polymyositis and dermatomyositis.Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 casesPredictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprineAn overview of polymyositis and dermatomyositis.Paraneoplastic dermatomyositis with carcinoma cervix: a rare clinical association.A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositisSafety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.Prognosis of polymyositis and dermatomyositis.Causes of creatine kinase levels greater than 1000 IU/L in patients referred to rheumatologyIncreased Cumulative Incidence of Dermatomyositis in Ulcerative Colitis: a Nationwide Cohort StudyDistribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositisInflammatory myopathies: One-center experience.Idiopathic inflammatory myopathies: current and future therapeutic options.Does computed tomography-based muscle density predict muscle function and health-related quality of life in patients with idiopathic inflammatory myopathies?Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study.Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Polymyositis associated with hypothyroidism or hyperthyroidism: two cases and review of the literature.Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand.Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain.Dermatomyositis: factors predicting relapse.Cardiac Abnormalities in Adult Patients With Polymyositis or Dermatomyositis as Assessed by Noninvasive Modalities.Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study.Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak General Hospital.High association of mycobacterial infections with polymyositis in a non-endemic country for tuberculosis.Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study.Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study.Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan.Quantitative 3D scintigraphy shows increased muscular uptake of pyrophosphate in idiopathic inflammatory myopathy.Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study.
P2860
Q27025125-BF2B447F-3B28-4F5E-92E8-E3785F22B67BQ28079786-DB71213C-04AB-4B6E-A03D-A185006AD193Q33397195-3D125640-9C2C-40DF-89EC-E904BC713322Q33715014-6E967754-AEB5-472E-B106-9D9CD622EED5Q33924451-56387A28-594E-40AB-B84C-75B1F5957C9CQ33926524-3B7CBBAC-FA5C-4287-8341-08902D70661DQ34070882-41CCDEA6-BCAF-4561-B0FB-A6F2A610A3C5Q34260708-2D77B3BF-4C61-4C1A-9483-313D819386E2Q34495766-D7FCB016-BB2A-4A6D-B2AA-BA5F6DB75C2BQ34635470-81566562-ECA3-4CB6-8E08-AADD3942858CQ34667765-0D795EE4-014F-4F4E-97B9-F307F81EED08Q34798861-B0EF4024-A4AD-4A37-B73A-B1C354496D04Q35498610-C0E786CE-2DB0-47B8-9AE3-025099D34054Q35557832-61D72C45-C2D6-4568-B404-A6E6A4BF7486Q35900966-CC5E26BF-67D0-419F-85D8-A1996AFFC71FQ36283423-8E745A21-3271-47B2-A15E-889C7CD4200CQ36461742-2D6CDE7F-3CB7-4002-8EB8-1CE6D022462DQ36913435-55967063-9FEB-4016-B926-7F24603515EFQ37023992-5A357BB1-A555-4479-8CD2-67D71B9D53A6Q37080228-8EF23325-F2B3-4107-8905-4118A86D266DQ37296359-2ABD85B0-D423-4A6A-A5B3-9267B1DF67DDQ37329526-BB67DFAE-C5C0-4A65-AB17-9ABA826470D6Q37551973-71E3B52A-AEF6-44CD-8491-880B7E1DF9FAQ37587375-C9BF4C6B-23EB-4361-BC07-635D42E04CB1Q37704799-DB4F9DD3-8E5A-423B-9E2E-03D6D84FF644Q37790632-F470D127-8696-4D72-A200-6037188E8D6FQ39028925-489B4BBB-69E7-4E4E-A4BE-9A0FA14991BFQ40069189-EDD2D4B5-548A-4625-847E-651F1C39AE21Q40209605-A6D9ECC6-4FA0-4237-8722-0B0491C446F9Q40391930-772F42AB-6D5F-4AAA-B086-1F0C47EAFE31Q40479785-3E6A13ED-9DFC-4F13-839D-247D3925B520Q40534854-CA217C28-36F6-496A-A4D2-62F32DC6BF93Q40742414-2A5D6962-06C5-4AD2-AF10-8FC9F8FC3D95Q41933878-E8DA9DB1-196D-4EEB-9F15-1E8022269BFEQ42339969-014E796B-C17B-4FFD-B4B1-A9813CF6FF74Q43589261-C8D07830-293A-4319-AB61-B9E8E8C04807Q43833930-2A7F2A57-9E56-4455-A737-9D73C1F6A8B9Q45791610-D5AD1A4A-C475-4EDA-B1A6-B4A5EE5D44FCQ47100192-C363E498-59D7-416D-9C52-2747BC9D1011Q47238762-5ECF6B05-F4EC-4E52-B769-C1A9ABA669FE
P2860
Prognosis and mortality of polymyositis and dermatomyositis patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prognosis and mortality of polymyositis and dermatomyositis patients.
@en
Prognosis and mortality of polymyositis and dermatomyositis patients.
@nl
type
label
Prognosis and mortality of polymyositis and dermatomyositis patients.
@en
Prognosis and mortality of polymyositis and dermatomyositis patients.
@nl
prefLabel
Prognosis and mortality of polymyositis and dermatomyositis patients.
@en
Prognosis and mortality of polymyositis and dermatomyositis patients.
@nl
P2093
P2860
P921
P1476
Prognosis and mortality of polymyositis and dermatomyositis patients.
@en
P2093
P2860
P304
P356
10.1007/S10067-005-1164-Z
P577
2006-02-14T00:00:00Z